BriaCell Therapeutics Corp.
TSX:BCT.TOBiotechnology
Healthcare
$5.75 +18.88%
+$0.94 today
- Market cap
- $50.02M
- Beta
- 1.53
- P/E (TTM)
- -0.3
- EPS (TTM)
- -$4.23
52W Low $3.68High $20.40
Volume 0.00M
Average 0.01M
BCT.TO EBITDA Margin
EBITDA as a percentage of revenue.
No reported EBITDA Margin figures are available to summarize.
EBITDA Margin history
Percent of revenue · from the income statement
No EBITDA Margin data reported for this period type.
EBITDA Margin vs competitors
How BCT.TO compares with its peers on the latest reported figures
No competitor EBITDA Margin figures are available to compare.
Income Statement
USD
Metric | FY2021 Jul 2021 | FY2022 Jul 2022 | FY2023 Jul 2023 | FY2024 Jul 2024 | FY2025 Jul 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | 15.55K | 0 | 0 | 0 | 107.93K |
| Gross Profit | (15.55K) | 0 | 0 | 0 | (107.93K) |
| Gross Margin | — | — | — | — | — |
| Research & Development | 2.02M | 8.02M | 15.34M | 27.18M | 21.53M |
| Selling, General & Admin | 4.96M | 7.27M | 7.94M | 6.15M | 5.9M |
| Operating Expenses | 6.97M | 15.29M | 23.27M | 33.33M | 27.43M |
| Depreciation & Amortization | 15.55K | 15.27K | 15.27K | 83.9K | 107.93K |
| EBITDA | (7.1M) | (26.82M) | (23.26M) | (4.85M) | (27.43M) |
| EBITDA Margin | — | — | — | — | — |
| Operating Income | (7.11M) | (15.29M) | (23.27M) | (33.33M) | (27.54M) |
| Operating Margin | — | — | — | — | — |
| Interest Income | 3.21K | 136.73K | 891.21K | 288.02K | 121.42K |
| Interest Expense | 80.09K | 979 | 0 | 0 | 37.43K |
| Other Income / Expenses | (6.84M) | (11.55M) | 2.97M | 28.4M | 656.6K |
| Income Before Tax | (13.82M) | (26.84M) | (20.3M) | (4.93M) | (26.88M) |
| Pre-Tax Margin | — | — | — | — | — |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 |
| Net Income | (13.82M) | (26.84M) | (20.3M) | (4.79M) | (26.63M) |
| Net Margin | — | — | — | — | — |
| EPS (Basic) | (467.51) | (259.50) | (195.00) | (43.68) | (62.95) |
| EPS (Diluted) | (467.51) | (259.50) | (195.00) | (43.68) | (62.95) |
| Weighted Avg Shares | 30.13K | 103.29K | 104.13K | 109.7K | 423.11K |
| Weighted Avg Shares (Diluted) | 30.13K | 103.29K | 104.13K | 109.7K | 423.11K |
BriaCell Therapeutics Corp.
TSX:BCT.TO
Intrinsic Alpha fair value
Locked
Current Price
$5.75
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.